2017
DOI: 10.1080/21678707.2017.1279050
|View full text |Cite|
|
Sign up to set email alerts
|

Pathogenesis and treatment options for hemophilic synovitis

Abstract: Introduction: Hemophilia is characterized by recurrent bleeding episodes, most commonly in the knees, elbows and ankles. Repeated hemarthroses lead to synovial hypertrophy and a vicious cycle of chronic synovitis arises, leading to destruction of the joint. Areas covered: This article covers the pathogenesis of chronic hemophilic synovitis and its treatment by means of different types of synovectomy. Expert opinion: Both radioynovectomy (RS) and arthroscopic synovectomy considerably improve the frequency of bl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 53 publications
0
1
0
Order By: Relevance
“…This phenomenon is called chronic haemophilic synovitis, and it is predisposed to re-bleeding, ultimately leading to a dangerous cycle of haemarthrosis-synovitis-haemarthrosis. 9 If we fail to stop that cycle, the joint cartilage will ultimately be destroyed due to the death of the chondrocytes, advancing within a few years to haemophilic arthropathy 1 (Figure 1). These circumstances substantially impact the quality of life of these individuals, particularly in cases of severe haemophilia (< 1% circulating factor) and in those who present an inhibitor (antibody opposed to the intravenously infused deficient factor).…”
mentioning
confidence: 99%
“…This phenomenon is called chronic haemophilic synovitis, and it is predisposed to re-bleeding, ultimately leading to a dangerous cycle of haemarthrosis-synovitis-haemarthrosis. 9 If we fail to stop that cycle, the joint cartilage will ultimately be destroyed due to the death of the chondrocytes, advancing within a few years to haemophilic arthropathy 1 (Figure 1). These circumstances substantially impact the quality of life of these individuals, particularly in cases of severe haemophilia (< 1% circulating factor) and in those who present an inhibitor (antibody opposed to the intravenously infused deficient factor).…”
mentioning
confidence: 99%